Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GLP-1
Regulatory
Trump order aims to revive "most favored nation" policy
Trump is reintroducing his controversial "most favored nation" policy aiming to lower the cost of prescription drugs.
Noah Tong
May 12, 2025 9:30am
Hims & Hers eyes $6.5B revenue target by 2030
May 5, 2025 5:00pm
Novo Nordisk taps Hims & Hers, LifeMD and Ro for GLP-1 tie-up
Apr 29, 2025 5:15pm
Nutrition counseling startup Nourish clinches $70M to expand
Apr 23, 2025 1:46pm
CMS excludes anti-obesity drug coverage under Medicare, Medicaid
Apr 4, 2025 4:28pm
Knownwell joins Lilly Direct; Hims & Hers adds weight loss meds
Apr 3, 2025 11:30am
